Estimating the impact of direct acting antiviral therapy on the prevalence of hepatitis C virus infection using phylogenetics

Estimating the impact of direct acting antiviral therapy on the prevalence of hepatitis C virus infection using phylogenetics

Introduction: Australia has provided unrestricted subsidized access to direct-acting antiviral (DAA) treatment for hepatitis C virus (HCV) infection since 2016. Epidemiological surveillance estimates suggest prevalence of chronic HCV infection has declined since 2016, but these estimates are not sep...

Full description

Saved in:
Bibliographic Details
Main Authors: Hossain M.S. Sazzad, Hui Li, Behzad Hajarizadeh, Bethany A. Horsburgh, Jason Grebely, Gregory J. Dore, Rowena A. Bull, Andrew R. Lloyd, Chaturaka Rodrigo
Format: Article
Language:English
Published: Elsevier 2025-05-01
Series:Virus Research
Subjects:
Hepatitis C virus
Bayesian evolutionary analysis
People who inject drugs
Australia
Prisons
Online Access:http://www.sciencedirect.com/science/article/pii/S0168170225000437
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items